Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 5,211 | 5,995 | -3,562 | 44,165 |
| Cost of Goods | N/A | 2,639 | 2,860 | 29,857 | 15,033 |
| Gross Profit | N/A | 2,572 | 3,135 | -33,419 | 29,132 |
| Operating Expenses | 0 | 16,974 | 35,871 | 59,219 | 19,722 |
| Operating Income | N/A | -13,763 | -31,876 | -91,781 | 9,443 |
| Interest Expense | 0 | 312 | 474 | 2,454 | 3,011 |
| Other Income | 0 | 69 | -13,890 | 60,296 | -26,342 |
| Pre-tax Income | 0 | -14,006 | -46,240 | -33,939 | -19,910 |
| Income Tax | N/A | -1,077 | -14,473 | 2,318 | -1,944 |
| Net Income Continuous | N/A | -12,929 | -31,767 | -36,257 | -17,966 |
| Net Income Discontinuous | N/A | -37,399 | -244 | N/A | N/A |
| Minority Interests | N/A | -357 | -288 | 60 | -182 |
| Net Income | $N/A | $-49,971 | $-31,723 | $-54,888 | $-17,784 |
| EPS Basic Total Ops | N/A | -0.43 | -0.26 | -0.44 | -0.16 |
| EPS Basic Continuous Ops | N/A | -0.11 | -0.26 | -0.30 | -0.16 |
| EPS Basic Discontinuous Ops | N/A | -0.32 | 0.00 | N/A | N/A |
| EPS Diluted Total Ops | N/A | -0.43 | -0.26 | -0.44 | -0.16 |
| EPS Diluted Continuous Ops | N/A | -0.11 | -0.26 | -0.30 | -0.16 |
| EPS Diluted Discontinuous Ops | N/A | -0.32 | 0.00 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -0.20 | -0.18 | N/A | N/A |
| EBITDA(a) | $N/A | $-12,675 | $-30,567 | $-87,929 | $16,591 |